These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23529935)

  • 1. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review.
    Al-Bawardy R; Krishnaswamy A; Bhargava M; Dunn J; Wazni O; Tuzcu EM; Stewart W; Kapadia SR
    Clin Cardiol; 2013 May; 36(5):249-54. PubMed ID: 23529935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
    Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.
    Yuyun MF; Joseph J; Erqou SA; Kinlay S; Echouffo-Tcheugui JB; Peralta AO; Hoffmeister PS; Boden WE; Yarmohammadi H; Martin DT; Singh JP
    Europace; 2024 Jul; 26(7):. PubMed ID: 38812433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G; Levi T; Perelshtein Brezinov O; Valdman A; Rahkovich M; Kogan Y; Laish-Farkash A
    Isr Med Assoc J; 2022 Jan; 24(1):25-32. PubMed ID: 35077042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.
    Taramasso M; Gavazzoni M; Pozzoli A; Alessandrini H; Latib A; Attinger-Toller A; Biasco L; Braun D; Brochet E; Connelly KA; de Bruijn S; Denti P; Deuschl F; Estevez-Louriero R; Fam N; Frerker C; Ho E; Juliard JM; Kaple R; Kodali S; Kreidel F; Kuck KH; Lauten A; Lurz J; Monivas V; Mehr M; Nazif T; Nickening G; Pedrazzini G; Praz F; Puri R; Rodés-Cabau J; Schäfer U; Schofer J; Sievert H; Tang GHL; Khattab AA; Thiele H; Unterhuber M; Vahanian A; Von Bardeleben RS; Webb JG; Weber M; Windecker S; Winkel M; Zuber M; Hausleiter J; Lurz P; Maisano F; Leon MB; Hahn RT
    JACC Cardiovasc Interv; 2020 Mar; 13(5):554-564. PubMed ID: 31954676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
    Murphy SP; Lew J; Yucel E; Singh J; Mela T
    J Cardiovasc Electrophysiol; 2024 May; 35(5):1017-1025. PubMed ID: 38501386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricuspid Regurgitation Related to Cardiac Implantable Electronic Devices: An Integrative Review.
    Gelves-Meza J; Lang RM; Valderrama-Achury MD; Zamorano JL; Vargas-Acevedo C; Medina HM; Salazar G
    J Am Soc Echocardiogr; 2022 Nov; 35(11):1107-1122. PubMed ID: 35964911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead-related tricuspid regurgitation and ventricle dysfunction: Current management and future perspectives.
    Chodór-Rozwadowska KE; Sawicka M; Morawski S; Lenarczyk R; Kalarus Z; Kukulski T
    Adv Clin Exp Med; 2023 Sep; 32(9):1049-1061. PubMed ID: 36881368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dilemma of transvenous cardiac rhythm devices in hemodialysis patients: time to consider the epicardial approach?
    Asif A; Salman LH; Lopera GG; Carrillo RG
    Kidney Int; 2011 Jun; 79(12):1267-9. PubMed ID: 21625255
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricuspid valve incompetence following implantation of ventricular leads.
    Baquero GA; Luck J; Naccarelli GV; Gonzalez MD; Banchs JE
    Curr Heart Fail Rep; 2015 Apr; 12(2):150-7. PubMed ID: 25488281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
    Cheng Y; Gao H; Tang L; Li J; Yao L
    Echocardiography; 2016 Nov; 33(11):1689-1696. PubMed ID: 27539645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
    Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricuspid Valve Dysfunction Caused by Right Ventricular Leads.
    Ebrille E; Chang JD; Zimetbaum PJ
    Card Electrophysiol Clin; 2018 Sep; 10(3):447-452. PubMed ID: 30172281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features of Lead-Induced Tricuspid Regurgitation in Patients With Heart Failure Events After Cardiac Implantation of Electronic Devices　- A Three-Dimensional Echocardiographic Study.
    Nakajima H; Seo Y; Ishizu T; Iida N; Sato K; Yamamoto M; Machino-Ohtsuka T; Nogami A; Ohte N; Ieda M
    Circ J; 2020 Nov; 84(12):2302-2311. PubMed ID: 33071243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricuspid regurgitation and implantable devices.
    Al-Bawardy R; Krishnaswamy A; Rajeswaran J; Bhargava M; Wazni O; Wilkoff B; Tuzcu EM; Martin D; Thomas J; Blackstone E; Kapadia S
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):259-66. PubMed ID: 25377489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-term results after isolated tricuspid valve surgery in the presence of right ventricular leads.
    Pfannmueller B; Budde LM; Etz CD; Noack T; Marin-Cuartas M; Misfeld M; Borger MA
    J Cardiovasc Surg (Torino); 2021 Oct; 62(5):510-514. PubMed ID: 33829746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe tricuspid regurgitation secondary to dislodgement of the atrial loop into the right ventricle: an unusual complication of pacemaker implantation in a young adult.
    Arapoglu M; Celiker A; Ozkan S
    Acta Cardiol; 2012 Apr; 67(2):235-8. PubMed ID: 22641982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.